» Articles » PMID: 33591315

SAMHD1 Restrains Aberrant Nucleotide Insertions at Repair Junctions Generated by DNA End Joining

Overview
Specialty Biochemistry
Date 2021 Feb 16
PMID 33591315
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Aberrant end joining of DNA double strand breaks leads to chromosomal rearrangements and to insertion of nuclear or mitochondrial DNA into breakpoints, which is commonly observed in cancer cells and constitutes a major threat to genome integrity. However, the mechanisms that are causative for these insertions are largely unknown. By monitoring end joining of different linear DNA substrates introduced into HEK293 cells, as well as by examining end joining of CRISPR/Cas9 induced DNA breaks in HEK293 and HeLa cells, we provide evidence that the dNTPase activity of SAMHD1 impedes aberrant DNA resynthesis at DNA breaks during DNA end joining. Hence, SAMHD1 expression or low intracellular dNTP levels lead to shorter repair joints and impede insertion of distant DNA regions prior end repair. Our results reveal a novel role for SAMHD1 in DNA end joining and provide new insights into how loss of SAMHD1 may contribute to genome instability and cancer development.

Citing Articles

Functional conservation and divergence of arabidopsis VENOSA4 and human SAMHD1 in DNA repair.

Sarmiento-Manus R, Fontcuberta-Cervera S, Kawade K, Oikawa A, Tsukaya H, Quesada V Heliyon. 2025; 11(1):e41019.

PMID: 39801971 PMC: 11720913. DOI: 10.1016/j.heliyon.2024.e41019.


Understanding the interplay between dNTP metabolism and genome stability in cancer.

Yague-Capilla M, Rudd S Dis Model Mech. 2024; 17(8).

PMID: 39206868 PMC: 11381932. DOI: 10.1242/dmm.050775.


Identification and evaluation of small-molecule inhibitors against the dNTPase SAMHD1 via a comprehensive screening funnel.

Zhang S, Paulin C, Shu H, Yague-Capilla M, Michel M, Marttila P iScience. 2024; 27(2):108907.

PMID: 38318365 PMC: 10839966. DOI: 10.1016/j.isci.2024.108907.


Guanine-containing ssDNA and RNA induce dimeric and tetrameric structural forms of SAMHD1.

Orris B, Sung M, Bhat S, Xu Y, Huynh K, Han S Nucleic Acids Res. 2023; 51(22):12443-12458.

PMID: 37930833 PMC: 10711556. DOI: 10.1093/nar/gkad971.


Targeting SAMHD1: To overcome multiple anti-cancer drugs resistance in hematological malignancies.

Wang T, Liu P, Yang J Genes Dis. 2023; 10(3):891-900.

PMID: 37396510 PMC: 10308132. DOI: 10.1016/j.gendis.2022.06.001.


References
1.
Wang Y, Su P, Hu B, Zhu W, Li Q, Yuan P . Characterization of 26 deletion CNVs reveals the frequent occurrence of micro-mutations within the breakpoint-flanking regions and frequent repair of double-strand breaks by templated insertions derived from remote genomic regions. Hum Genet. 2015; 134(6):589-603. DOI: 10.1007/s00439-015-1539-4. View

2.
Gu J, Lu H, Tippin B, Shimazaki N, Goodman M, Lieber M . XRCC4:DNA ligase IV can ligate incompatible DNA ends and can ligate across gaps. EMBO J. 2007; 26(4):1010-23. PMC: 1852838. DOI: 10.1038/sj.emboj.7601559. View

3.
Lee E, Seo J, Park J, Thuy Lu Vo T, An S, Bae S . SAMHD1 acetylation enhances its deoxynucleotide triphosphohydrolase activity and promotes cancer cell proliferation. Oncotarget. 2017; 8(40):68517-68529. PMC: 5620274. DOI: 10.18632/oncotarget.19704. View

4.
Coquel F, Silva M, Techer H, Zadorozhny K, Sharma S, Nieminuszczy J . SAMHD1 acts at stalled replication forks to prevent interferon induction. Nature. 2018; 557(7703):57-61. DOI: 10.1038/s41586-018-0050-1. View

5.
Ghezraoui H, Piganeau M, Renouf B, Renaud J, Sallmyr A, Ruis B . Chromosomal translocations in human cells are generated by canonical nonhomologous end-joining. Mol Cell. 2014; 55(6):829-842. PMC: 4398060. DOI: 10.1016/j.molcel.2014.08.002. View